ABSTRACT
Traditional Chinese medicine has played an important role in the prevention and control of COVID-19. However, the relevant legal support is not perfect enough, and there are still some blind spots and controversies in legal supervision, which bring difficulties to the prevention practice of medical institutions. The existing problems include: the basis for the selection of prophylactic prescription is vague; the donation and distribution of prophylactic Chinese medicine are lack of standardized system; the attribute positioning of batch prepared prophylactic prescription products is controversial; it is difficult to implement large-scale prophylactic medication by one prescription for one person; the department for prescribing prophylactic prescription is not clear; the construction of Internet diagnosis and treatment service is insufficient; enterprises and units cannot issue prescription for prophylactic medicine; and some items of the existing prescription format are difficult to be filled in accurately. In this regard, it is proposed to further supplement and improve the relevant laws and regulations, and strengthen the legal management of traditional Chinese medicine in epidemic prevention.